Kai He
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 58
- Cancer Immunotherapy and Biomarkers 33
- Lung Cancer Research Studies 15
- CAR-T cell therapy research 12
- Co-authors
- David P. Carbone (31 shared papers)Elias Aizenman (4 shared papers)Stuart J. Frank (14 shared papers)Dwight H. Owen (19 shared papers)Gregory A. Otterson (24 shared papers)Erin M. Bertino (17 shared papers)Peter G. Shields (17 shared papers)Marie-Anne Damiette Smit (1 shared paper)
- Journals
- Journal of Clinical Oncology (15 papers)Journal of Thoracic Oncology (11 papers)Annals of Oncology (5 papers)Molecular Endocrinology (5 papers)Cancer Research (4 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Kai He
108 papers receiving 2.4k citations
Kai He's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 1.1k
- Immunology 502
- Cancer Research 335
- Endocrinology, Diabetes and Metabolism 276
- Molecular Biology 999
Countries citing papers authored by Kai He
This map shows the geographic impact of Kai He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai He more than expected).
Fields of papers citing papers by Kai He
This network shows the impact of papers produced by Kai He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai He. The network helps show where Kai He may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 221 | |
| 2 | 2019 | 163 | |
| 3 | 2007 | 117 | |
| 4 | 2018 | 111 | |
| 5 | 2019 | 101 | |
| 6 | 2021 | 87 | |
| 7 | 2019 | 82 | |
| 8 | 2008 | 80 | |
| 9 | 2010 | 66 | |
| 10 | Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors Hit paper breakdown → | 2024 | 62 |
| 11 | 2002 | 62 | |
| 12 | 2005 | 58 | |
| 13 | 2003 | 54 | |
| 14 | 2018 | 49 | |
| 15 | 2019 | 47 | |
| 16 | 2005 | 45 | |
| 17 | 2004 | 44 | |
| 18 | 2006 | 40 | |
| 19 | 2024 | 39 | |
| 20 | 2018 | 38 |
About Kai He
Kai He is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 114 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (33 papers), Lung Cancer Treatments and Mutations (21 papers), Cancer Genomics and Diagnostics (17 papers), Lung Cancer Research Studies (15 papers), CAR-T cell therapy research (12 papers), Growth Hormone and Insulin-like Growth Factors (12 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Oncology (1.1k citations), Immunology (502 citations), Cancer Research (335 citations), Endocrinology, Diabetes and Metabolism (276 citations) and Molecular Biology (999 citations). Kai He has collaborated with scholars based in United States, China and Spain. Frequent co-authors include David P. Carbone, Elias Aizenman, Stuart J. Frank, Dwight H. Owen, Gregory A. Otterson, Erin M. Bertino, Peter G. Shields, Marie-Anne Damiette Smit, Julie M. Bailis and Junran Zhang. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Molecular Endocrinology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.